LNTH250117P130000
- 31.00
- 0.000.00%
Lantheus Newsroom
Lantheus Increases to 12.16% Shareholding in Radiopharm With US$5m (A$8m) Placement
Radiopharm Theranostics Raises $5 Million Via Private Placement to Lantheus, Shares Surge 58%
Market Mover | Radiopharm Theranostics shares jump 45% on a A$8 million placement agreement
Here's What Lifted Lantheus Holdings (LNTH) in Q3
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Radiopharm Theranostics Partners With Lantheus on Oncology Radiopharmaceuticals Development; Shares Up 9%
Express News | Lantheus Holdings Inc - Revolving Line of Credit Increased to $750 Million
Express News | Lantheus Holdings Inc - Enters First Amendment to Credit Agreement
Truist Financial Maintains Lantheus(LNTH.US) With Buy Rating
Lantheus (LNTH) Gets a Buy From Truist Financial
Will Weakness in Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Stock Prove Temporary Given Strong Fundamentals?
Lantheus Holdings CMO Jeff Humphrey to Depart
Express News | Lantheus Holdings Inc - CEO Brian Markison and President Paul Blanchfield Assume Interim R&D Leadership
Express News | Lantheus Holdings Inc - Jeff Humphrey No Longer Cmo at Lantheus Holdings
P/E Ratio Insights for Lantheus Holdings
This Box Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Lantheus Holdings Analyst Ratings
Goldman Sachs Initiates Lantheus(LNTH.US) With Buy Rating, Announces Target Price $143
Analysts Offer Insights on Healthcare Companies: Lantheus (LNTH) and Qiagen (QGEN)
Here's How Much You Would Have Made Owning Lantheus Holdings Stock In The Last 5 Years